Search Tag: HYPERION
Targeted Temperature Management After Cardiac Arrest
2020 11 Jan
Post-anoxic brain damage after cardiac arrest is a complex condition that is managed through targeted temperature management (TTM) as it is currently the only neuroprotective intervention recommended after out-of-hospital cardiac arrest (OHCA). However, experts have raised concerns about the level of evidence supporting this intervention. Two early... Read more
Top ICU Stories of 2019
2019 28 Dec
As we move into 2020, here's a quick recap of our most clicked stories in ICU in 2019: Using Biomarkers for Mortality Prediction in Patients With Sepsis A new study evaluated the prognostic value of six biomarkers at onset of sepsis in adult patients with sepsis or septic shock. Risk Factors for Frailty and Death in the ICU... Read more
Targeted Temperature Management: HYPERION Trial
2019 11 Oct
Moderate therapeutic hypothermia is recommended in patients with persistent coma after resuscitated out-of-hospital cardiac arrest in order to improve neurologic outcomes. But its effectiveness in patients with nonshockable rhythm still remains unclear. Findings from the HYPERION Trial were presented at the European Society of Intensive Care Medicine... Read more